Key facts
- Notable investors include Ecole Polytechnique Federale de Lausanne, BID Equity, University of Basel.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Crisalix
- ·The full record, as it builds
Funding rounds
No funding rounds for Crisalix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Crisalix
Developer of a cosmetic surgery simulator software designed to offer 3D aesthetic simulation. The company uses artificial intelligence, computer vision and augmented reality allowing users to visualize the face or body in 3D, enabling surgeons to answer several questions for their patients within the aesthetic and reconstructive medical field.
- Sector
- Healthcare
- HQ
- Lausanne, Switzerland
- Founded
- 2008
- Employees
- 160
- Website
- crisalix.com/
- Ownership
- Privately Held (backing)
Crisalix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Crisalix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Crisalix in its N-PORT filings yet. We sweep new filings monthly.